Kymera Therapeutics, Inc. Logo

Kymera Therapeutics, Inc.

Fintech firm providing data analytics and market intelligence for investment professionals.

KYMR | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
500 NORTH BEACON STREET, 4TH FLOOR, 2472 WATERTOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kymera Therapeutics, Inc. is a revolutionary financial technology firm redefining investment paradigms through targeted data analytics. Leveraging its powerful and highly productive data discovery engine, the company delivers a pipeline of first-in-class analytics and market intelligence solutions for financial institutions and investment professionals. Kymera's platform provides a market-agnostic modality for discovering alpha and managing risk, fundamentally changing how clients access and utilize data. The firm is committed to delivering transformative insights with precision, focus, and a sense of urgency to a global client base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:15
Quarterly Report
10-Q - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 2.2 MB
2025-11-04 13:10
Regulatory News Service
8-K - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 225.9 KB

Automate Your Workflow. Get a real-time feed of all Kymera Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kymera Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kymera Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Advancing high-grade copper and precious metal projects from discovery to production.
Canada COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.